REQUEST A DEMO
Total
USD $0.00
Search more companies

Intermercatus Biotech S.A. (Poland)

Main Activities: Medical and Diagnostic Laboratories
Secondary Activities: Pharmaceutical and Medicine Manufacturing | Research and Development in the Physical, Engineering, and Life Sciences | Office Administrative Services
Full name: Intermercatus Biotech S.A. Profile Updated: December 19, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2021 Available in: English & Polish Download a sample report

Intermercatus Biotech S.A. is an enterprise located in Poland, with the main office in Warsaw. The company operates in the Medical and Diagnostic Laboratories industry. It was established on February 10, 2016. There are currently 1 (2016) people employed by Intermercatus Biotech S.A.. Its’ total assets recorded a negative growth of 7.21%.

Headquarters
Ul. Pulawska 221/1
Warsaw; Mazowieckie; Postal Code: 02-715

Contact Details: Purchase the Intermercatus Biotech S.A. report to view the information.

Website: http://www.intermercatus.com

Basic Information
Total Employees:
Purchase the Intermercatus Biotech S.A. report to view the information.
Registered Capital:
Purchase the Intermercatus Biotech S.A. report to view the information.
Financial Auditors:
Purchase the Intermercatus Biotech S.A. report to view the information.
Incorporation Date:
February 10, 2016
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Company Performance
Financial values in the chart are available after Intermercatus Biotech S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total operating revenue
1419650%
Operating profit (EBIT)
21.19%
EBITDA
39.76%
Net Profit (Loss) for the Period
21.19%
Total Assets
-7.21%
Total Equity
-57.27%
Return on Equity (ROE)
-61.36%
Debt/Equity
305.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?